Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment

Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment

Lidia Habtemikael,1 Mulugeta Russom,2 Iyassu Bahta,2 Selam Mihreteab,3 Araia Berhane,4 Andreas Mårtensson,1 Jose Pedro Gil1,5,6 1Department of Women’s and Children’s Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden; 2National M...

Full description

Bibliographic Details
Main Authors: Habtemikael L, Russom M, Bahta I, Mihreteab S, Berhane A, Mårtensson A, Gil JP
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
malaria
uncomplicated
artesunate/amodiaquine
cyp2c8
slow metabolizers.
Online Access:https://www.dovepress.com/prevalence-of-cyp2c82-and-3-amongnbsperitreans-and-its-potential-impac-peer-reviewed-article-PGPM

Similar Items

Similar Items